Items where Author is "Durrant, LG"

BRENTVILLE, V.A., VANKEMMELBEKE, M., METHINGHAM, R.L., SYMONDS, P., COOK, K.W., URBANOWICZ, R.A., TSOLERIDIS, T., COLEMAN, C.M., CHANG, K.-C., SKINNER, A., DUBININA, E., DANIELS, I., POCKLEY, A.G., SHAH, S., DIXON, J.E., ADAMS, S.E., PASTON, S.J., DALY, J.M., BALL, J.K. and DURRANT, L.G., 2021. A novel bivalent DNA vaccine encoding both spike protein receptor-binding domain and nucleocapsid protein of SARS-CoV-2 to elicit T cell and neutralising antibody responses that cross react with variants. Cold Spring Harbor Laboratory. (Submitted)

PEARSON, J.R.D., CUZZUBBO, S., MCARTHUR, S., DURRANT, L.G., ADHIKAREE, J., TINSLEY, C.J., POCKLEY, A.G. and MCARDLE, S.E.B., 2020. Immune escape in glioblastoma multiforme and the adaptation of immunotherapies for treatment. Frontiers in Immunology, 11: 582106.

MCGILVRAY, R.W., EAGLE, R.A., WATSON, N.F.S., AL-ATTAR, A., BALL, G., JAFFERJI, I., TROWSDALE, J. and DURRANT, L.G., 2009. NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting. Clinical Cancer Research, 15 (22), pp. 6993-7002. ISSN 1078-0432

RAMAGE, J.M., METHERINGHAM, R., MOSS, R., SPENDLOVE, I., REES, R. and DURRANT, L.G., 2004. Comparison of the immune response to a self antigen after DNA immunisation of HLA*A201/H-2Kb and HHD transgenic mice. Vaccine, 22 (1314), pp. 1728-1731. ISSN 0264-410X

RAMAGE, J.M., METHERINGHAM, R., CONN, A., SPENDLOVE, I., MOSS, R.S., PATTON, D.T., MURRAY, J.C., REES, R.C. and DURRANT, L.G., 2004. Identification of an HLA-A*0201 cytotoxic T lymphocyte epitope specific endothelial antigen Tie-2. International Journal of Cancer, 110 (2), pp. 245-250. ISSN 0020-7136